Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 9, Issue 1, 2008, Pages 32-36

  Arfa, Imen ^a   Abid, Abdelmajid ^c   Nouira, Sonia ^a   Elloumi Zghal, Houda ^a   Malouche, Dhafer ^b   Mannai, Imen ^a,b   Zorgati, Mohamed Majdi ^a   Alaya, Nissaf Ben ^a   Rebai, Ahmed ^d   Zouari, Béchir ^e   Ammar, Slim Ben ^a   Rayana, Mohamed Chiheb Ben ^c   Hmida, Slama ^f   Blousa Chabchoub, Samira ^c   Abdelhak, Sonia ^a  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b UNIVERSITY OF CARTHAGE   (Tunisia)

^c Institut National de Nutrition Tunis   (Tunisia)

^d CENTRE DE BIOTECHNOLOGIE DE SFAX   (Tunisia)

^e UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^f Centre National de Transfusion Sanguine Tunis   (Tunisia)

Author keywords

Angiotensin converting enzyme; Diabete nephropathy; Insertion deletion polymorphism; Type 2 diabetes

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIET RESTRICTION; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HETEROZYGOTE DETECTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TUNISIA;

AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DNA TRANSPOSABLE ELEMENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; SEQUENCE DELETION; TUNISIA;

EID: 42249085432     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2008.002     Document Type: Article

References (42)

1. De Silva SNT, Weerasuriya N, De Alwis NM, De Silva MW, Fernando DJ. Excess maternal transmission and familial aggregation of Type 2 diabetes in Sri Lanka. Diabetes Res Clin Pract 2002;58:173-7.
2. Barnett AH, Eff C, Leslie RD, Pyke DA. Diabetes in identical twins. A study of 200 pairs. Diabetologia 1981;20:87-93.
3. Rossing P, Rossing K, Jacobsen P, Parving HH. Unchanged incidence of diabetic nephropathy in IDDM patients. Diabetes 1995;44 739-43.
4. Freedman BI, Tuttle AB, Spray BJ. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis 1995;25:710-71.
5. Faronato PP, Maioli M, Tonolo G et al. Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. The Italian NIDDM Nephropathy Study Group. Diabetologia 1997;40 816-23.
6. Wong TY, Poon P, Szeto CC, Chan JC, Li PK. Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients. Kidney Int 2000;57:632-8.
7. Hansen PM, Chowdhury T, Deckert T, Hellgren A, Bain SC, Pociot F. Genetic variation of the heparan sulfate proteoglycan gene (perlecan gene). Association with urinary albumin excretion in IDDM patients. Diabetes 1997;46:1658-9.
8. Chowdhury TA, Dyer PH, Kumar S et al. Association of apolipoprotein epsilon2 allele with diabetic nephropathy in Caucasian subjects with IDDM. Diabetes 1998;47:278-80.
9. Hall JE, Guyton AC, Jackson TE, Coleman TG, Lohmeier TE, Trippodo NC. Control of glomerular filtration rate by renin-angiotensin system. Am J Physiol 1977;233:366-72.
10. Hostetter TH, Troy JL, Brenner BM. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1981;19:410-15.
11. Ballerman BJ, Zeidel ML, Gunning ME, Brenner BM. (1991). Vasoactive peptides and the kidney. In The Kidney. 4th ed. Brenner BM, Rector FC, Eds. Philadelphia, Saunders, p. 510-83.
12. Erdos EG. Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension 1990;16:363-70.
13. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986;77:1925-30.
14. Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 1988;297:1092-5.
15. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993;329:1456-62.
16. Jauch KW, Hartl W, Guenther B, Wicklmayr M, Rett K, Dietze G. Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1987; 17:448-54.
17. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
18. Tiret L, Rigat B, Visvikis S et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:97-205.
19. Hadjadj S, Gallois Y, Alhenc-Gelas F et al. Angiotensin-I-converting enzyme insertion/deletion polymorphism and high urinary albumin concentration in French Type 2 diabetes patients. Diabet Med 2003;20:677-82.
20. Hsieh MC, Lin SR, Hsieh TJ et al. Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan. Nephrol Dial Transplant 2000;15:1008-13.
21. Schmidt S, Schone N, Ritz E. Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int 1995;47:1176-81.
22. Singh PP, Naz I, Gilmour A, Singh M, Mastana S. Association of APOE (Hha1) and ACE (I/D) gene polymorphisms with type 2 diabetes mellitus in North West India. Diabetes Res Clin Pract 2006;74:95-102.
23. Feng Y, Niu T, Xu X et al. Insertion/deletion polymorphism of the ACE gene is associated with type 2 diabetes. Diabetes 2002;51 1986-8.
24. Grammer TB, Renner W, Von Karger S, Boehm BO, Winkelmann BR, Maerz W. The angiotensin-I converting enzyme I/D polymorphism is not associated with type 2 diabetes in individuals undergoing coronary angiography. (The Ludwigshafen Risk and Cardiovascular Health Study). Mol Genet Metab 2006;88:378-83.
25. Marre M, Jeunemaitre X, Gallois Y et al. Contribution of Genetic Polymorphism in the Renin-Angiotensin System to the development of Renal Complications in Insulin-dependent diabetes. J Clin Invest 1997; 99:1585-95.
26. Huang W, Gallois Y, Bouby N et al. Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse. Proc Natl Acad Sci USA 2001;98:1330-4.
27. Zingone A, Dominijanni A, Mele F et al. Deletion polymorphism in the gene for angiotensin converting enzyme is associated with elevated fasting blood glucose levels. Hum Genet 1994;94:207-09.
28. Rebai M, Kharrat N, Ayadi I, Rebai A. Haplotype structure of five SNPs within the ACE gene in the Tunisian population. Ann Hum Biol 2006;33:319-29.
29. Solini A, Vestra M, Saller A, Nosadini R, Crepaldi G, Fioretto P. The angiotensin-converting enzyme DD genotype is associated with glomerulopathy lesions in type 2 diabetes. Diabetes 2002;51 251-5.
30. Crook ED, Genous L, Oliver B. Angiotensin-converting enzyme genotype in blacks with diabetic nephropathy: Effects on risk of diabetes and its complications. J Investig Med 2003;51:360-5.
31. Shestakova MV, Vikulova OK, Gorashko NM et al. The relationship between genetic and haemodynamic factors in diabetic nephropathy (DN): Case-control study in type 1 diabetes mellitus (T1DM). Diabetes Res Clin Pract 2006 [Epub ahead of print].
32. Buraczynska M, Ksiazek P, Lopatynski J, Spasiewicz D, Nowicka T, Ksiazek A. Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes. Pol Arch Med Wewn 2002;108 725-30.
33. Ng DP, Tai BC, Koh D, Tan KW, Chia KS. Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: A meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Diabetologia 2004;48:1008-16.
34. Hadjadj S, Belloum R, Bouhanick B et al. Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: A prospective study. J Am Soc Nephrol 2001; 12:541-9.
35. Schmidt S, Strojek K, Grzeszczak W, Bergis K, Ritz E. Excess of DD homozygotes in haemodialysed patients with type II diabetes. The Diabetic Nephropathy Study Group. Nephrol Dial Transplant 1997; 12:427-9.
36. Parving HH, Jacobsen P, Tarnow L et al. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study. BMJ 1996;313:591-4.
37. Penno G, Chaturvedi N, Talmud PJ et al. Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM. Diabetes 1998;47 1507-11.
38. So WY, Ma RC, Ozaki R et al. Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients-interaction with ACE insertion/ deletion polymorphism. Kidney Int 2006;69:1438-43.
39. Stephens JW, Dhamrait SS, Cooper JA et al. The D allele of the ACE I/D common gene variant is associated with Type 2 diabetes mellitus in Caucasian subjects. Mol Genet Metab 2005;84:83-9.
40. Huang XH, Rantalaiho V, Wirta O et al. Relationship of the angiotensin-converting enzyme gene polymorphism to glucose intolerance, insulin resistance, and hypertension in NIDDM. Hum Genet 1998; 102:372-8.
41. Torlone E, Rambotti AM, Perriello G et al. ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension. Diabetologia 1991; 34:119-25.
42. Aguilar D, Solomon SD. ACE-inhibitors and angiotensin receptor antagonists and the incidence of new-onset diabetes mellitus: An emerging theme. Drugs 2006;66:1169-77.